Phase II Trial of the CDK4 Inhibitor PD0332991 in Patients With Advanced CDK4-Amplified Well-Differentiated or Dedifferentiated Liposarcoma von DICKSON, Mark A, TAP, William D, USTOYEV, Yelena, CRAGO, Aimee M, SINGER, Samuel, SCHWARTZ, Gary K, KEOHAN, Mary Louise, D'ANGELO, Sandra P, GOUNDER, Mrinal M, ANTONESCU, Cristina R, LANDA, Jonathan, QIN, Li-Xuan, RATHBONE, Dustin D, CONDY, Mercedes M

Volltext

Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified liposarcoma von Dickson, Mark Andrew, Tap, William D., Keohan, Mary Louise, D'Angelo, Sandra P., Gounder, Mrinal M., Chi, Ping, Antonescu, Cristina R., Landa, Jonathan, Qin, Li-Xuan, Rathbone, Dustin D., Ustoyev, Yelena, Crago, Aimee Marie, Singer, Samuel, Schwartz, Gary K., Condy, Mercedes M.

Volltext

Phase II trial of the CDK4 inhibitor PD0332991 in CDK4-amplified liposarcoma von Dickson, Mark Andrew, Keohan, Mary Louise, Tap, William D., Antonescu, Cristina, Landa, Jonathan, Qin, Li-Xuan, Dohrenwend, Eric Gerard, Rathbone, Dustin, Ustoyev, Yelena, Condy, Mercedes M, Singer, Samuel, Schwartz, Gary K.

Volltext